Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.
- NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_assertion description "[Combination of SFN with (-)-epigallocatechin gallate as a demethylating agent is identified as an effective approach for re-expression of estrogen receptor in hormone negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.
- NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_assertion evidence source_evidence_literature NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.
- NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_assertion SIO_000772 23657153 NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.
- NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_assertion wasDerivedFrom befree-20140225 NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.
- NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_assertion wasGeneratedBy ECO_0000203 NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP810839.RAAk4P4Keuw9EeFf2tcWkC0v9KDxy2L1tbAOeT8ktrpIQ130_provenance.